Updated Proxy Filed and Q4 Results Released
iKang Healthcare Group (ADR) (KANG US) simultaneously reported its March quarter results and filed the updated proxy for its privatization at...
365 Views
Trade Risks Start to Impact, as China Biotech Ambitions Grow…
Cyclical indicators are softening this month - new orders index for the Philly Fed fell nearly 23 points while Japan’s PMI new export orders...
126 Views
Wuxi Biologics Placement - Probably Not a Surprise to Sell Again when Lock-Up Expires
Biologics Holdings is looking to sell 50m shares of WuXi Biologics (Cayman) Inc. (2269 HK) worth about US$500m. Post sale, Biologics Holdings will...
337 Views
Ping An Good Doctor IPO Review - Step Aside, Valuation. Solving Problems Come First.
Ping An Healthcare And Techn (1833 HK) is looking to raise about US$1bn from its upcoming IPO and proceeds will be mainly used for business...
578 Views
ECM Weekly Update - Blocks Bigger than IPOs, Videos, Hotels, Education, Banks, Missiles, Biologics..
As the title suggests, its been an exceptionally busy week and since Toh Zhen Zhou is still on a beach in Bali, hence, this weekly by your's...
179 Views